Key Insights

Highlights

Success Rate

83% trial completion

Published Results

42 trials with published results (17%)

Research Maturity

111 completed trials (45% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.2%

23 terminated out of 249 trials

Success Rate

82.8%

-3.7% vs benchmark

Late-Stage Pipeline

10%

25 trials in Phase 3/4

Results Transparency

38%

42 of 111 completed with results

Key Signals

42 with results83% success23 terminated

Data Visualizations

Phase Distribution

162Total
Not Applicable (122)
Early P 1 (4)
P 1 (6)
P 2 (5)
P 3 (9)
P 4 (16)

Trial Status

Completed111
Unknown44
Recruiting36
Terminated23
Withdrawn12
Active Not Recruiting9

Trial Success Rate

82.8%

Benchmark: 86.5%

Based on 111 completed trials

Clinical Trials (249)

Showing 20 of 20 trials
NCT07116525Not ApplicableRecruiting

A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter

NCT07585968Not ApplicableNot Yet RecruitingPrimary

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

NCT05511246Phase 2RecruitingPrimary

Venous Ethanol for Ventricular Tachycardia

NCT07324031Not ApplicableRecruiting

Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

NCT06281977Phase 3RecruitingPrimary

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

NCT05478213Not ApplicableRecruitingPrimary

Ventricular Tachycardia Mechanisms

NCT07607821Not ApplicableNot Yet Recruiting

Validation of ECG-Based Ventricular Arrhythmia Localization Algorithms in Patients With Repaired Tetralogy of Fallot

NCT06294028Not ApplicableRecruiting

International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction

NCT04747353Not ApplicableCompletedPrimary

Computed Tomography Targets for Efficient Guidance of Catheter Ablation in Ventricular Tachycardia (MAP-IN-HEART)

NCT05855135Not ApplicableActive Not Recruiting

Assessment of Combined CCM and ICD Device in HFrEF

NCT06005428Phase 2Terminated

Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT05225935Not ApplicableCompletedPrimary

Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia

NCT07590908CompletedPrimary

CARA-VT: a Dosimetric in Silico Study

NCT06203262Not ApplicableCompleted

Ventricular Catheter Ablation Study (VCAS)

NCT06647459TerminatedPrimary

Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation

NCT06575881Recruiting

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

NCT02114528Phase 4TerminatedPrimary

Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention

NCT03049254Recruiting

Mayo AVC Registry and Biobank

NCT05599022Not ApplicableRecruitingPrimary

Randomized Assessment of TcMS for VT Storm

NCT06593418Not ApplicableNot Yet RecruitingPrimary

Cardiac Radioablation for VT

Scroll to load more

Research Network

Activity Timeline